Insights

Friends or Enemies: Process Improvement and Innovation in the Pharmaceutical Industry

“Process stifling our innovation”!  “These extra meetings slow down our decision-making”! “Project management is distracting us from the real work that needs to get done”! “We have zero flexibility”! Unfortunately, these are commonly held beliefs in many organizations that believe having process discipline and rigor negatively impact productivity.  Consider what...

Read More

The Practice of Change | Part II | Transition

Running From Change:  Employee Transition in the Wake of Organizational Shift.   Once companies have communicated there is going to be change, how do you persuade them to stay with your organization?  It’s not 2008-2011 when opportunities were scarce — those with strong education and training, good performance records, and current...

Read More

The Practice of Change | Part I | Communication

The first in a three-part series on how businesses have redrawn the map after economic headwinds After the seismic economic shift we witnessed between 2008 and 2012 – whether it was induced by business downturns, right sizing, outsourcing, or merger / acquisition – it became evident that something had to...

Read More

Street Talk: A Mid-Year Review of Challenges and Trends

Over the last six months, members of the TayganPoint team have been both speaking at and attending a variety of conferences in the area of Life Sciences, Health Care, Shared Services, Regulatory and Technology Advancement.  During our travels, we’ve encountered a number of emerging trends we feel are worth sharing. ...

Read More

How Customer Centric is Your Strategy?

No one would argue that development of the proper business strategy and then execution of that strategy is a core competency of most successful organizations.  And yet we find clients who are very good at setting strategy around any number of business facets; and yet they fail to define a...

Read More

The Hammers and Nails of R&D Portfolio Management:  A Fool With a Tool is Still a Fool 

After attending a recent R&D portfolio and resource management conference, and listening to presenters from both large, established, and rising star pharmaceutical companies and life science organizations, we were surprised to hear how many companies were grappling with issues related to transparency and consistency of data, the ability to drive...

Read More

Archives